Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

8.3%

1 terminated/withdrawn out of 12 trials

Success Rate

88.9%

+2.4% vs industry average

Late-Stage Pipeline

25%

3 trials in Phase 3/4

Results Transparency

25%

2 of 8 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

Phase 3
3(37.5%)
Phase 1
2(25.0%)
N/A
1(12.5%)
Phase 2
1(12.5%)
Early Phase 1
1(12.5%)
8Total
Phase 3(3)
Phase 1(2)
N/A(1)
Phase 2(1)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (12)

Showing 12 of 12 trials
NCT00512577Phase 3Terminated

Transfusion Alternatives Pre-operatively in Sickle Cell Disease (TAPS)

Role: collaborator

NCT05600608Not ApplicableUnknown

Augmentation of Volatile Biomarkers of Oesophageal and Gastric Adenocarcinoma From the Tumour Lipidome

Role: collaborator

NCT05487079Unknown

Identification and Characterization of Diabetes in Low-resource Populations

Role: collaborator

NCT05361083Early Phase 1Completed

First-in-human Evaluation of [18F]CETO

Role: collaborator

NCT00649961Phase 2Completed

Melatonin As A Novel Neuroprotectant In Preterm Infants- Dosage Study

Role: collaborator

NCT03432962Completed

Brand Level Nutrient Information Compared to Generic Food Codes

Role: collaborator

NCT03251287Phase 1Unknown

Nitrite in Hypertrophic Cardiomyopathy (HCM) Study

Role: collaborator

NCT00182819Phase 3Completed

Radiation Therapy or Temozolomide in Treating Patients With Gliomas

Role: collaborator

NCT00844597Phase 1Completed

Dose-Ranging Study of AVI-4658 to Induce Dystrophin Expression in Selected Duchenne Muscular Dystrophy (DMD) Patients

Role: collaborator

NCT01168869Completed

Myocardial Infarction as the First Manifestation of Coronary Heart Disease: Rates of Heralded and Unheralded Myocardial Infarction

Role: collaborator

NCT01335672Completed

Survival After First Myocardial Infarction in Patients With and Without Chronic Obstructive Pulmonary Disease

Role: collaborator

NCT00144365Phase 3Completed

Comparison of Facility and Home-based ART Delivery Systems in Uganda

Role: collaborator

All 12 trials loaded